Table 5 Associations of genetic polymorphisms in GSTT1, GSTM1, GSTT1, and TYMS with individual types of toxicity

From: Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option

 

Dermatological toxicity

Haematological toxicity

Gastrointestinal toxicity

Genitourinary toxicity

 

Grade 0–2

Grade 3–4

P -value a

Grade 0–2

Grade 3–4

P -value a

Grade 0–2

Grade 3–4

P -value a

Grade 0–2

Grade 3-4

P -value a

GSTT1

Not NULL

61 (81%)

14 (19%)

0.040

72 (96%)

3 (4%)

0.300

73 (97%)

2 (3%)

0.527

73 (97%)

2 (3%)

0.527

NULL

12 (57%)

9 (43%)

 

19 (90%)

2 (10%)

 

20 (95%)

1 (5%)

 

20 (95%)

1 (5%)

 

GSTM1

Not NULL

29 (76%)

9 (24%)

1.000

36 (95%)

2 (5%)

1.000

36 (95%)

2 (5%)

0.560

38 (100%)

0 (0%)

0.275

NULL

44 (76%)

14 (24%)

 

55 (95%)

3 (5%)

 

57 (98%)

1 (2%)

 

55 (95%)

3 (5%)

 

GSTP1

AA

36 (84%)

7 (16%)

0.223

42 (98%)

1 (2%)

0.376

42 (98%)

1 (2%)

1.000

42 (98%)

1 (2%)

1.000

AG or GG

38 (72%)

15 (28%)

 

49 (92%)

4 (8%)

 

51 (96%)

2 (4%)

 

51 (96%)

2 (4%)

 

TYMS 3’-UTR 6-bp ins/del

Ins/Ins

29 (74%)

10 (26%)

0.628

36 (92%)

3 (8%)

0.393

38 (97%)

1 (3%)

1.000

37 (95%)

2 (5%)

0.564

Ins/Del or Del/Del

45 (79%)

12 (21%)

 

55 (96%)

2 (4%)

 

55 (96%)

2 (4%)

 

56 (98%)

1 (2%)

 

TYMS 5’-UTR VNTR b

High expressor

30 (88%)

4 (12%)

0.075

32 (94%)

2 (6%)

1.000

34 (100%)

0 (0%)

0.550

34 (100%)

0 (0%)

0.550

Low expressor

44 (71%)

18 (29%)

 

59 (95%)

3 (5%)

 

59 (95%)

3 (5%)

 

59 (95%)

3 (5%)

 
  1. Abbreviations: GSTM1=glutathione S-transferase mu; GSTP1=glutathione S-transferase pi; GSTT1=glutathione S-transferase theta; TYMS=thymidylate synthase; VNTR=variable number of 28-bp tandem repeats.
  2. aFisher’s exact test (two-sided).
  3. bLow TYMS expression genotypes are (*2/*2, *2/*3C and *3C/*3C) and high TYMS expression genotypes (*2/*3G, *3C/*3G or *3G/*3G).